Evidence map›Paper›PMID 37501887›Full record

ArticleJournal of neuroendovascular therapy2023

Endovascular Embolization of Femoral Pseudoaneurysm Associated with Therapeutic and Diagnostic Neuroendovascular Procedures.

Saiko Watanabe, Ryuzaburo Kanazawa, Takanori Uchida, Tetsuhiro Higashida, Kei Yamazaki, Takao Kono

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroendovascular therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. [Management of pseudoaneurysm associated with endovascular treatments at third level].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Saiko WatanabeDepartment of Neurosurgery, Nagareyama Central Hospital, Nagareyama, Chiba, Japan.
Ryuzaburo KanazawaDepartment of Neurosurgery, Nagareyama Central Hospital, Nagareyama, Chiba, Japan.
Takanori UchidaDepartment of Neurosurgery, Nagareyama Central Hospital, Nagareyama, Chiba, Japan.
Tetsuhiro HigashidaDepartment of Neurosurgery, Nagareyama Central Hospital, Nagareyama, Chiba, Japan.
Kei YamazakiDepartment of Neurosurgery, Nagareyama Central Hospital, Nagareyama, Chiba, Japan.
Takao KonoDepartment of Neurosurgery, Nagareyama Central Hospital, Nagareyama, Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: We aimed to evaluate the usefulness of endovascular embolization for femoral iatrogenic pseudoaneurysms (PAs) following therapeutic and diagnostic neuroendovascular procedures. Methods: This study included 12 patients with femoral PA due to femoral puncture at our department between May 2014 and April 2021. We performed an analysis of baseline characteristics, treatment, and outcome of these cases. Results: Endovascular embolization was performed in 10 of the 12 PAs using coils and/or N-butyl-2-cyanoacrylate. Of these, 10 PAs were treated with endovascular embolization and 9 were successfully occluded, whereas complete occlusion was not achieved in 1 case of PA (success rate: 90%). No new intraoperative or postoperative complications or postoperative recurrences occurred. Conclusion: Endovascular embolization for PA can be immediately performed under local anesthesia without discontinuation of antithrombotic therapy and may be a safe and effective option for access site complication treatment.

Indexed as

access site complicationcommon femoral arteryendovascular embolizationneuroendovascular procedurespseudoaneurysm

Identifiers

PMID37501887
PMCPMC10370512
OpenAlexW4313054802

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.